It will be interesting to see how well Waymo does with snow!
29 karma · joined December 12, 2022
The real challenge lies in the expectations the FDA has set for manufacturing. Over time, the regulatory space has been heavily influenced by academic-driven theoretical scenarios for microbiological contamination. While well-intentioned, these theoretical risks often drive overly stringent requirements that don’t always reflect real-world manufacturing risks.
As a result, it’s becoming prohibitively expensive to manufacture drugs for the U.S., especially sterile injectables.
And truly it gets worse every year…
Hopefully this now gets more support with the antics that Twitter has pulled with these 3rd party clients.
You won’t get a title without making the payments…